KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Change in Receivables (2017 - 2025)

Twist Bioscience (TWST) has disclosed Change in Receivables for 9 consecutive years, with -$6.8 million as the latest value for Q4 2025.

  • Quarterly Change in Receivables fell 250.45% to -$6.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.0 million through Dec 2025, up 165.45% year-over-year, with the annual reading at $22.4 million for FY2025, 365.06% up from the prior year.
  • Change in Receivables for Q4 2025 was -$6.8 million at Twist Bioscience, down from $7.2 million in the prior quarter.
  • The five-year high for Change in Receivables was $10.7 million in Q1 2025, with the low at -$8.1 million in Q4 2023.
  • Average Change in Receivables over 5 years is $1.2 million, with a median of $1.8 million recorded in 2022.
  • The sharpest move saw Change in Receivables plummeted 328.28% in 2022, then surged 1531.96% in 2025.
  • Over 5 years, Change in Receivables stood at $2.0 million in 2021, then skyrocketed by 101.67% to $4.1 million in 2022, then crashed by 296.63% to -$8.1 million in 2023, then soared by 156.3% to $4.5 million in 2024, then plummeted by 250.45% to -$6.8 million in 2025.
  • According to Business Quant data, Change in Receivables over the past three periods came in at -$6.8 million, $7.2 million, and -$87000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.